Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
29 September-02 October, 2025
Not Confirmed
Not Confirmed
29 September-01 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
29 September-02 October, 2025
Industry Trade Show
Not Confirmed
29 September-01 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
12 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/12/3149131/0/en/Progress-in-clinical-development-for-Alzheimer-s-and-other-indications-Galimedix-Therapeutics-successfully-completes-Phase-1-study-with-oral-small-molecule-GAL-101-an-amyloid-beta-.html
12 Sep 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/galimedix-seeks-phase-2-funding-after-oral-alzheimers-candidate-clears-safety-test
21 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/21/3085672/0/en/Galimedix-Therapeutics-publishes-new-data-in-peer-reviewed-International-Journal-of-Molecular-Sciences-demonstrating-disease-modifying-capability-of-GAL-201-in-Alzheimer-s-disease.html
06 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/06/3075003/0/en/Galimedix-Therapeutics-completes-single-ascending-dose-part-of-Phase-1-study-with-oral-small-molecule-GAL-101-an-amyloid-beta-aggregation-modulator.html
23 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/23/3001385/0/en/Galimedix-Therapeutics-initiates-pivotal-Phase-2-study-with-GAL-101-eye-drops-in-dry-AMD.html
08 Mar 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/03/08/2842923/0/en/Galimedix-Therapeutics-presents-new-scientific-data-showing-promising-neuroprotective-effects-of-GAL-201-for-the-treatment-of-Alzheimer-s-disease-at-AD-PD-2024.html
ABOUT THIS PAGE